glp 1 medication where to buy GLP-1 Medications for Weight Loss 1 pathway Personalized GLP-1 Medication (Injection)

10.2337/dc12-2006

The content contained in this article is for informational purposes only

GLP-1 (glucagon-like peptide-1) receptor agonists are medications used primarily to treat type 2 diabetes and support weight loss

All participants who had more than one episode of DKA were from the SGLT2i group

*FOR ORAL SEMAGLUTIDE USED FOR WEIGHT-LOSS SOURCE: New England Journal of Medicine

They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain